Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Robin Foà: Sustainability and Accessibility of CAR-T Cell Therapy

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 28th 2022

We are delighted to speak with Dr Robin Foà, one of our Editorial Board members for touchREVIEWS in Oncology & Haematology, to discuss the sustainability and accessibility of CAR-T Cell Therapy as well as the challenges associated with this treatment.

Questions

  1. Could you give us a brief overview of the current approval status of CAR-T cell therapy? (00:15-02:21)
  2. At present, is CAR-T cell therapy worth the high direct and indirect costs? (02:21-04:45)
  3. How can we reduce the costs associated with CAR-T cell therapy? (04:45-08:12)
  4. What are the challenges associated with the availability and accessibility of CAR-T cell therapy? (08:12-09:55)
  5. How can we improve efficacy and safety outcomes with these therapies? (09:55-12:11)
  6. How do you see the use of CAR-T cell therapy evolving in the coming years? (12:11-14:50)

Speaker Disclosure: Robin Foà has no financial or non-financial conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup